Testicular Cancer
📧 Sign up to get email alerts when something new happens for Testicular Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-08-22Clinical Trial Update: Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle
This clinical trial update reports on research analyzing transposon control pathways in germ cell tumors of the testis.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence [Phase 2]
Phase 2 study evaluating FluGlucoScan (F-fluorodeoxyglucose) in patients with known or suspected cancers; the trial status is completed.
-
CLINICAL_TRIALS withdrawal · 2016-01-26Clinical Trial Update: Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP) [Phase 4]
A Phase 4 pharmacokinetic study of aprepitant in BEP treatment for testicular cancer has been withdrawn.
-
FDA approval · 2015-08-20FDA Approved: BLEOMYCIN — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Bleomycin submitted by Hospira, Inc., updating the product's indications or labeling.
-
CLINICAL_TRIALS research · 2015-06-25Clinical Trial Update: Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Completed MSK clinical trial examining patient perspectives on the risks of ionizing radiation from medical imaging across several cancer ty…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer [Phase 2]
Phase 2 clinical trial of everolimus for relapsed/refractory germ cell cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Physical Activity and Testicular Cancer [NA]
The clinical trial NCT01749774 evaluating physical activity in individuals with testicular cancer has completed, as reported by Oslo Univers…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
This completed clinical trial evaluates cardiac function and cardiovascular risk in patients with testicular cancer, including seminoma and …
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors [Phase 2]
A Phase 2 trial comparing conventional-dose chemotherapy with high-dose sequential chemotherapy for poor-prognosis germ cell tumors has comp…
-
CLINICAL_TRIALS research · 2014-03-24Clinical Trial Update: REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg
This entry notes the completion of a retrospective study of testicular cancer patients conducted at the University of Magdeburg.
-
FDA approval · 2012-11-13FDA Approved: CISPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for cisplatin filed by Fresenius Kabi USA, LLC. This action confirms the continued approval of cispl…
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Phase 1]
Phase 1 trial evaluating intravenous palifosfamide-tris in combination with etoposide and carboplatin in patients with various malignancies;…
-
CLINICAL_TRIALS research · 2012-03-26Clinical Trial Update: Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk [NA]
A terminated clinical trial sponsored by Centre Hospitalier Universitaire de Nice investigating predictive markers for testicular cancer in …
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
FDA approval · 2011-08-26FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the …
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II [Phase 2]
Phase 2 TAXIF II evaluated high-dose chemotherapy with autologous stem cell transplantation in patients with poor-prognosis germ-cell tumors…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Relationship of Ochratoxin A to Upper Urologic Cancers
A completed clinical trial examined the relationship between Ochratoxin A exposure and upper urinary tract cancers, including transitional c…
-
CLINICAL_TRIALS research · 2008-10-24Clinical Trial Update: Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy [Phase 2]
Phase 2 trial evaluating sorafenib as a monotherapy for inoperable or recurrent germ cell carcinoma refractory to chemotherapy. The conditio…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [Phase 1]
Phase 1 feasibility study evaluating interleukin-1 alpha in combination with Ifosfamide, Carboplatin, and Etoposide with autologous bone mar…
-
FDA approval · 2008-01-28FDA Approved: BLEOMYCIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA's original ANDA for bleomycin sulfate, making a generic version of bleomycin available. Bleomycin is an …